[
    {
        "PMCID": "10487629",
        "Article_title": "Meta-Analysis of Heat-Stressed Transcriptomes Using the Public Gene Expression Database from Human and Mouse Samples",
        "description": "The text provided appears to be an excerpt from a scientific paper or report detailing the methodology and results of a study on gene expression in response to heat shock (HS) in human and mouse models. The study involves high-throughput sequencing data analysis to identify genes that are upregulated or downregulated in response to HS. Here is a summary of the sections provided:**2. Results****2.1. Overview of Analysis Scheme**- The analysis scheme is outlined, with subsequent sections detailing various aspects of the study.**2.2. Characteristics of HS-Related High-Throughput Sequencing Data**- The study collected gene expression data from public databases, including 66 Sequence Read Archive (SRA) IDs and 564 pairs of gene expression data from human and mouse samples.- The data included various sequencing methods like RNA-seq and Ribo-seq.- Metadata for the collected data is available in figshare files.**2.3. Verification of Upregulated and Downregulated Genes in Each Organism**- Gene expression was quantified, and expression ratios (HN-ratios) were calculated.- Genes were classified as upregulated, downregulated, or unchanged based on a defined threshold.- HN-scores were calculated for all genes to detect variable expression.- Gene set enrichment analysis was performed using Metascape, identifying significant GO terms for upregulated and downregulated gene groups.**2.4. Identification of Common Upregulated or Downregulated Genes in Human and Mouse**- Genes common to both human and mouse samples were identified and analyzed.- Mouse Genome Informatics (MGI) was used to convert human gene symbols to mouse orthologs.- A scatter plot was created to evaluate the distribution of HN-scores for the common genes.- Enrichment analysis was performed to characterize the common upregulated and downregulated genes.**2.5. Integration of HN-score, Transcription Factor-Binding Information, and Literature Information**- Enrichment analysis of transcription factor target genes was conducted, focusing on HSF1, HSF2, and PPARGC1A.- ChIP-seq data from the ChIP-Atlas database was integrated with HN-score results.- Scatter plots were used to visualize the relationship between ChIP-seq scores, HN-scores, and the number of research reports for each gene.The study aims to understand the genetic response to heat shock by analyzing gene expression data and identifying common patterns between human and mouse models. The integration of various data types, including high-throughput sequencing, transcription factor-binding information, and literature data, allows for a comprehensive analysis of the genes involved in the heat shock response."
    },
    {
        "PMCID": "10157352",
        "Article_title": "A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma",
        "description": "The provided text appears to be an excerpt from a scientific study that investigates the role of microRNAs (miRNAs) in osteosarcoma, a type of bone cancer, as well as their potential as biomarkers for disease prognosis and differentiation from other bone tumors. Here's a summary of the key points from the text:**Patient Characteristics:**- The osteosarcoma study included 30 patients (20 male, 10 female) with a mean age of 24 years.- All patients had high-grade osteosarcoma, with most tumors located in the appendicular skeleton.- No distant metastasis was observed at presentation.- The mean tumor size was 9.7 cm.- Patients were classified into different tumor stages (IIA, IIB, III) according to the AJCC 8th staging classification.- Most patients underwent surgery after neoadjuvant chemotherapy and received adjuvant chemotherapy.- The mean follow-up period was 108 months, with some patients experiencing local recurrence or distant metastasis, and some dying from the disease.**Survival Rates and miRNA Analysis:**- The study identified optimal cut-off points for various miRNAs to predict outcomes like death, distant metastasis, and disease-free status.- High serum levels of miR-146a-5p, miR-1260a, and miR-487b-3p were associated with improved overall survival.- High serum levels of miR-1260a, miR-487b-3p, miR-1260b, and miR-4758-3p were associated with improved distant metastasis-free survival.- High serum levels of miR-1260a, miR-1260b, and miR-4758-3p were associated with improved disease-free survival.**Differentiation from Other Bone Tumors:**- Serum miR-1261 levels were significantly higher in osteosarcoma patients compared to healthy controls and patients with other bone tumors.- Other miRNAs did not show marked differences between osteosarcoma patients and those with other bone tumors, although levels were higher than in healthy controls.**Effect of miR-1261 on Cellular Viability and Proliferation:**- Inhibition of miR-1261 did not significantly affect cell viability or proliferation in osteosarcoma cell lines.**Effect of miR-1261 on Target Genes:**- Inhibition of miR-1261 increased mRNA levels of CDH6 and SETD2 but not KIF26B in 143B cells.- Addition of miR-1261 mimic decreased mRNA levels of KIF26B and SETD2 but not CDH6 in HOS cells.The study suggests that certain miRNAs may serve as biomarkers for osteosarcoma prognosis and could help differentiate osteosarcoma from other bone tumors. Additionally, miR-1261 seems to regulate genes associated with osteosarcoma, although its direct impact on cell viability and proliferation was not statistically significant in this study."
    }
]